Facioscapulohumeral muscular dystrophy

Current Opinion in Neurology

Volumn 22, Issue 5, 2009, Pages 539-542

  Padberg, George W ^a   Van Engelen, Baziel G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

D4Z4 repeat; Facioscapulohumeral muscular dystrophy; Genetic; Mechanisms

Indexed keywords

ANGIOGENESIS; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE DELETION; HUMAN; MUSCLE DEVELOPMENT; MUSCLE WEAKNESS; PATHOGENESIS; REVIEW; TRANSCRIPTION REGULATION;

DNA METHYLATION; HUMANS; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; MUTATION; UP-REGULATION;

EID: 70349664564     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328330a572     Document Type: Review

References (24)

1. Mosctacciulo ML, Pastorello E, Vazza G, et al. Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-west Italian population sample. Clin Genet 2009; 75:550-555.
2. Della Marca G, Frusciante R, Dittoni S, et al. Sleep disordered breathing in facioscapulohumeral muscular dystrophy. J Neurol Sci 2009 [Epub ahead of print].
3. Stübgen JP, Schultz G. Lung and respiratory muscle function in facioscapulohumeral muscular dystrophy. Muscle Nerve 2009; 39:729-734.
4. Stübgen JP. Facioscapulohumeral muscular dystrophy: a radiologic and manometric study of the pharynx and esophagus. Dysphagia 2008; 23:341-347.
5. Trevisan CP, Pastorello E, Ermani M. Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function. Audiol Neurootol 2008; 13:1-6.
6. Trevisan CP, Pastorello E, Tomelleri G, et al. Facioscapulohumeral muscular dystrophy: hearing loss and other atypical features of patients with large 4q35 deletions. Eur J Neurol 2008; 15:1353-1358.
7. Stübgen JP, Schultz C. Lung and respiratory muscle function in facioscapulohumeral muscular dystrophy. Muscle Nerve 2009; 39:729-734.
8. Jensen MP, Hoffman AJ, Stoelb BL, et al. Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy. Arch Phys Med Rehabil 2008; 89:320-328.
9. Miro J, Raichle KA, Carter GT, et al. Impact of biopsychosocial factors on chronic pain in persons with myotonic and facioscapulohumeral muscular dystrophy. Am J Hosp Palliat Care 2009 [Epub ahead of print].
10. Kalkman JS, Zwarts MJ, Schillings ML, et al. Different types of fatigue in patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Experienced fatigue and physiological fatigue. Neurol Sci 2008; 29 (Suppl 2):S238-S240.
11. Schillings ML, Kalkman JS, Janssen HM, et al. Experienced and physiological fatigue in neuromuscular disorders. Clin Neurophysiol 2007; 118:292-300.
12. Kan HE, Scheenen TW, Wolhgemuth M, et al. Quantiative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 2009; 19:357-362.
13. Lemmers RJ, Wohlgemuth M, van der Gaag KJ, et al. Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy. Am J Hum Genet 2007; 81:884-894.
14. Gabellini D, D'Antona G, Moggio M, et al. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 2006; 439:937-947.
15. Osborne RJ, Welle S, Venance SL. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology 2007; 68:569-577.
16. Dixit M, Ansseau E, Tassin A, et al. DUX4, a candidate gene of facioscapulohumeral muscular dystropy encodes a transcriptional activator of PITX1. Proc Natl Acad Sci U S A 2007; 104:18157-18162.
17. Ottaviani A, Rival-Gervier S, Boussouar A, et al. The D4Z4 macrosatellite repeat acts as a CTCF and A-type lamins-dependent insulator in facioscapulo- humeral dystrophy. PLoS Genet 2009; 5:e1000394.
18. de Greef JC, Frants RR, van der Maarel SM, et al. Epigenetic mechanisms of facioscapulohumeral muscular dystrophy. Mutat Res 2008; 647:94-102.
19. Zeng FW, de Greef JC, Chen Y-Y. Specific loss of histone H3 lysine 9 trimethylation and HP1 g/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS Genet 2009; 5:1-14.
20. Petrov A, Pirozkhova I, Carnac G, et al. Chromatin loop domain organization within the 4q35 locus in facioscapulohumeral dystrophy patients versus normal human myoblasts. Proc Natl Acad Sci U S A 2006; 103:6982-6987.
21. Pirozhova I, Petrov A, Dmitriev P, et al. A functional role for 4qA/B in the structural rearrangement of the 4q35 region and in the regulation of FRG1 and ANT1 in facioscapulohumeral dystrophy. PLoS ONE 2008; 3:1-9.
22. Bakay M, Wang Z, Melcon G, et al. Nuclear envelope dystrophies show a transcritpional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. Brain 2006; 129 (Pt 4):996-1013.
23. Hanel ML, Wuebbles RD, Jones PL. Muscular dystrophy candidate gene FRG1 is critical for muscle development. Dev Dyn 2009; 238:1502-1512.
24. Wuebbles RD, Hanel ML, Jones PL. FSHD region 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy. Dis Model Mech 2009; 2:267-274.